Center For Structural Biology

Carterra Inc. and the Vanderbilt University School of Medicine Basic Sciences announced the addition of the Carterra LSAXT label-free interaction analysis platform to the Center for Structural Biology. Vanderbilt and Vanderbilt University Medical Center researchers will be able to discover and characterize large molecules including antibodies. Read More

Research from Teru Nakagawa, professor of molecular physiology and biophysics, describes intricacies of normal brain function with implications for our understanding of brain injury and recovery: A decrease in pH can modify a neurotransmitter receptor’s structure, thereby modulating its location and kinetics. Read More

Vanderbilt Environmental Health, Safety and Sustainability is launching the Vanderbilt Sustainable Labs program, which provides guidance for laboratory members to reduce the environmental impact of their lab activities. Read More

Brandt Eichman and Walter Chazin, professors of biochemistry, have worked together to provide a better understanding of how exactly DNA replication is initiated in eukaryotes. Using Vanderbilt’s state-of-the-art instrumentation in the Center for Structural Biology’s Cryo-Electron Microscopy Facility, Eichman, Chazin and their colleagues provided detailed visualizations of a multi-functional protein in action, which sheds light on how DNA replication is initiated in humans. Read More

Led by Terunaga Nakagawa, an international collaboration describes for the first time the fundamental mechanism underpinning cellular processes that lead to learning and memory. Read More

Vanderbilt scientists Katherine Aboud, PhD’19, Breann Brown and Will Wan, PhD’14, have received 2021 National Institutes of Health Director’s Awards for their unconventional, bold approaches to research that advances knowledge and enhances health. Read More

Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19. Read More

Borden Lacy, Edward and Nancy Fody Chair in Pathology and professor of biochemistry and pathology, microbiology and immunology, has been named director of the Vanderbilt Center for Structural Biology, effective Jan. 1. Read More

Vanderbilt researchers—including Charles Sanders, associate dean for research and professor of biochemistry, and graduate student Justin Marinko—have illuminated the cause of Charcot-Marie-Tooth disease, putting them on the road to developing therapeutic approaches for the disease that affects one in 2,500 people. Read More

A new cellular biology study reports the first visualization of a unique shape-shifting structure in the human body which plays an important role in the timely delivery of fats and proteins.  Read More